Cargando…
Behcet's Disease: Systemic and Ocular Manifestations
Aim. The aim of this study was to evaluate if patients with Behcet's disease who have ocular involvement have a more severe form of this disease as compared to patients with Behcet's disease alone. Methods. A total of 99 patients were included in the study. 76 patients were used as part of...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3808725/ https://www.ncbi.nlm.nih.gov/pubmed/24199188 http://dx.doi.org/10.1155/2013/247345 |
_version_ | 1782288621933428736 |
---|---|
author | Paovic, Jelena Paovic, Predrag Sredovic, Vojislav |
author_facet | Paovic, Jelena Paovic, Predrag Sredovic, Vojislav |
author_sort | Paovic, Jelena |
collection | PubMed |
description | Aim. The aim of this study was to evaluate if patients with Behcet's disease who have ocular involvement have a more severe form of this disease as compared to patients with Behcet's disease alone. Methods. A total of 99 patients were included in the study. 76 patients were used as part of the examined group, and 23 patients formed a control group. Results. The following are the results of examined and control groups, respectively: recurrent oral aphthous ulcers 89.5%, 95.7%; genital ulcers 61.8%, 97.0%; articular involvement 72.4%, 65.2%; vasculitis 81.6%, 60.9%; positive pathergy test 25.0%, 47.8%. Higher frequency of genital ulcerations was noted in control group (P = 0.001). More than two major criteria were met in 100% of the cases. HLA B51 was present in 78.9% of the cases in the examined group and 43.5% of the cases in control group; thus there is significant difference between them (P = 0.001). Visual acuity >0.5 occurred in 76% (examined group). Most frequent ocular manifestations in the examined group were retinal periphlebitis 81.6%, periphlebitis and periarteritis 65%, and serofibrinous uveitis 63.2%. Macular edema as a complication was present in 63.2%. The majority of patients (55.3%) were treated with combined therapy consisting of cyclosporine A and systemic corticosteroids. In 38.2% of patients, laser photocoagulation was used on retinal periphery. |
format | Online Article Text |
id | pubmed-3808725 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Hindawi Publishing Corporation |
record_format | MEDLINE/PubMed |
spelling | pubmed-38087252013-11-06 Behcet's Disease: Systemic and Ocular Manifestations Paovic, Jelena Paovic, Predrag Sredovic, Vojislav Biomed Res Int Clinical Study Aim. The aim of this study was to evaluate if patients with Behcet's disease who have ocular involvement have a more severe form of this disease as compared to patients with Behcet's disease alone. Methods. A total of 99 patients were included in the study. 76 patients were used as part of the examined group, and 23 patients formed a control group. Results. The following are the results of examined and control groups, respectively: recurrent oral aphthous ulcers 89.5%, 95.7%; genital ulcers 61.8%, 97.0%; articular involvement 72.4%, 65.2%; vasculitis 81.6%, 60.9%; positive pathergy test 25.0%, 47.8%. Higher frequency of genital ulcerations was noted in control group (P = 0.001). More than two major criteria were met in 100% of the cases. HLA B51 was present in 78.9% of the cases in the examined group and 43.5% of the cases in control group; thus there is significant difference between them (P = 0.001). Visual acuity >0.5 occurred in 76% (examined group). Most frequent ocular manifestations in the examined group were retinal periphlebitis 81.6%, periphlebitis and periarteritis 65%, and serofibrinous uveitis 63.2%. Macular edema as a complication was present in 63.2%. The majority of patients (55.3%) were treated with combined therapy consisting of cyclosporine A and systemic corticosteroids. In 38.2% of patients, laser photocoagulation was used on retinal periphery. Hindawi Publishing Corporation 2013 2013-10-03 /pmc/articles/PMC3808725/ /pubmed/24199188 http://dx.doi.org/10.1155/2013/247345 Text en Copyright © 2013 Jelena Paovic et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Clinical Study Paovic, Jelena Paovic, Predrag Sredovic, Vojislav Behcet's Disease: Systemic and Ocular Manifestations |
title | Behcet's Disease: Systemic and Ocular Manifestations |
title_full | Behcet's Disease: Systemic and Ocular Manifestations |
title_fullStr | Behcet's Disease: Systemic and Ocular Manifestations |
title_full_unstemmed | Behcet's Disease: Systemic and Ocular Manifestations |
title_short | Behcet's Disease: Systemic and Ocular Manifestations |
title_sort | behcet's disease: systemic and ocular manifestations |
topic | Clinical Study |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3808725/ https://www.ncbi.nlm.nih.gov/pubmed/24199188 http://dx.doi.org/10.1155/2013/247345 |
work_keys_str_mv | AT paovicjelena behcetsdiseasesystemicandocularmanifestations AT paovicpredrag behcetsdiseasesystemicandocularmanifestations AT sredovicvojislav behcetsdiseasesystemicandocularmanifestations |